Literature DB >> 8500174

Peptide contributes to the specificity of positive selection of CD8+ T cells in the thymus.

P G Ashton-Rickardt1, L Van Kaer, T N Schumacher, H L Ploegh, S Tonegawa.   

Abstract

Mice deficient in the gene encoding the peptide transporter associated with antigen processing (TAP1) have drastically reduced levels of surface expression of MHC class I molecules and few CD8+ T cells. Addition of class I binding peptides to cultured fetal thymi from TAP1 mutant mice invariably allowed the rescue of class I expression, while only some of these peptides promoted the positive selection of CD8+ T cells, which were polyclonal and specific for the peptide-MHC complex. A nonselecting peptide was converted to a mixture of selecting peptides when the residues involved in the interaction with TCRs were altered. A mixture of self-peptides derived from C57BL/6 thymi induced positive selection of CD8+ T cells at concentrations that gave relatively low class I surface expression. The implication of these observations is that self-peptides determine, in part, the repertoire of specificities exhibited by CD8+ T cells.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8500174     DOI: 10.1016/0092-8674(93)90281-t

Source DB:  PubMed          Journal:  Cell        ISSN: 0092-8674            Impact factor:   41.582


  68 in total

Review 1.  Treatment of an autoimmune disease with "classical" T cell veto: a proposal.

Authors:  U D Staerz; Y Qi
Journal:  J Clin Immunol       Date:  1999-07       Impact factor: 8.317

2.  Diversity of T cell repertoire shaped by a single peptide ligand is critically affected by its amino acid residue at a T cell receptor contact.

Authors:  Y Fukui; T Oono; J P Cabaniols; K Nakao; K Hirokawa; A Inayoshi; T Sanui; J Kanellopoulos; E Iwata; M Noda; M Katsuki; P Kourilsky; T Sasazuki
Journal:  Proc Natl Acad Sci U S A       Date:  2000-12-05       Impact factor: 11.205

Review 3.  Review article: thymus organ cultures and T-cell receptor repertoire development.

Authors:  G Anderson; E J Jenkinson
Journal:  Immunology       Date:  2000-08       Impact factor: 7.397

4.  Altered positive selection due to corecognition of floppy peptide/MHC II conformers supports an integrative model of thymic selection.

Authors:  Christophe Viret; Xin He; Charles A Janeway
Journal:  Proc Natl Acad Sci U S A       Date:  2003-04-16       Impact factor: 11.205

5.  Crossreactive recognition of viral, self, and bacterial peptide ligands by human class I-restricted cytotoxic T lymphocyte clonotypes: implications for molecular mimicry in autoimmune disease.

Authors:  I S Misko; S M Cross; R Khanna; S L Elliott; C Schmidt; S J Pye; S L Silins
Journal:  Proc Natl Acad Sci U S A       Date:  1999-03-02       Impact factor: 11.205

6.  The effects of thymic selection on the range of T cell cross-reactivity.

Authors:  Dennis L Chao; Miles P Davenport; Stephanie Forrest; Alan S Perelson
Journal:  Eur J Immunol       Date:  2005-12       Impact factor: 5.532

7.  Autoreactivity to self H-2Kb peptides in TAP1 mice. Intravenous administration of H-2Kb class I-derived peptides induces long-term survival of grafts from C57BL/6 donors.

Authors:  Idania Marrero; Luiz Alberto Benvenutti; Jorge Kalil; Verônica Coelho
Journal:  Immunology       Date:  2005-08       Impact factor: 7.397

8.  TCR Affinity for In Vivo Peptide-Induced Thymic Positive Selection Fine-Tunes TCR Responsiveness of Peripheral CD8+ T Cells.

Authors:  Umme Shahina Khanom; Izumi Ohigashi; Sayumi Fujimori; Kenta Kondo; Kensuke Takada; Yousuke Takahama
Journal:  J Immunol       Date:  2019-06-24       Impact factor: 5.422

Review 9.  Mycobacterium tuberculosis-specific CD8+ T cells and their role in immunity.

Authors:  Joshua S M Woodworth; Samuel M Behar
Journal:  Crit Rev Immunol       Date:  2006       Impact factor: 2.214

10.  Inhibition of intrathymic T cell development by expression of a transgenic antagonist peptide.

Authors:  C N Levelt; E Mizoguchi; X Huang; R Zacks; A K Bhan; S Tonegawa
Journal:  Proc Natl Acad Sci U S A       Date:  1998-11-24       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.